CCG-100602

• Description:

  CCG-100602 inhibits RhoA/C-mediated, SRF-driven luciferase expression in PC-3 prostate cancer cells (IC50 :9.8 µM) .

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  478.82

• Molecular Formula:

  C21H17ClF6N2O2

• Notes:

  Research use only, not for human use.

• Receptor:

  Rho

• CAS Number:

  1207113-88-9